David D. Moore
Impact in
- Pharmacology top 0.02%
- Pharmacogenetics and Drug Metabolism
- Hepatology top 0.2%
Papers in
- Oncology 55
- Drug Transport and Resistance Mechanisms 53
- Pharmacology 31
- Pharmacogenetics and Drug Metabolism 28
- Co-authors
- Wendong Huang (27 shared papers)Wongi Seol (9 shared papers)Hueng-Sik Choi (6 shared papers)P. Reed Larsen (14 shared papers)Dennis H. Dowhan (9 shared papers)Yoon‐Kwang Lee (18 shared papers)Howard M. Goodman (7 shared papers)Mohammed Qatanani (8 shared papers)
- Journals
- Molecular Endocrinology (23 papers)Hepatology (19 papers)Journal of Biological Chemistry (18 papers)Science (15 papers)Current Protocols in Molecular Biology (15 papers)
- Partner nations
- United StatesSouth KoreaChina
In The Last Decade
David D. Moore
268 papers receiving 31.7k citations
David D. Moore's Hit Papers
Peers
Comparison fields: 5 of 153
- Pharmacology 3.7k
- Hepatology 2.7k
- Oncology 6.9k
- Endocrine and Autonomic Systems 1.3k
- Endocrinology, Diabetes and Metabolism 2.8k
Countries citing papers authored by David D. Moore
This map shows the geographic impact of David D. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David D. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David D. Moore more than expected).
Fields of papers citing papers by David D. Moore
This network shows the impact of papers produced by David D. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David D. Moore. The network helps show where David D. Moore may publish in the future.
Co-authors
The 25 scholars most cited alongside David D. Moore, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 268 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Bile Acids: Natural Ligands for an Orphan Nuclear Receptor Hit paper breakdown → | 1999 | 1989 |
| 2 | Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma Hit paper breakdown → | 2017 | 1989 |
| 3 | Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c Hit paper breakdown → | 2004 | 1190 |
| 4 | Charon Phages: Safer Derivatives of Bacteriophage Lambda for DNA Cloning Hit paper breakdown → | 1977 | 855 |
| 5 | Human Growth Hormone as a Reporter Gene in Regulation Studies Employing Transient Gene Expression Hit paper breakdown → | 1986 | 632 |
| 6 | The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism Hit paper breakdown → | 2000 | 576 |
| 7 | Nuclear Receptor-Dependent Bile Acid Signaling Is Required for Normal Liver Regeneration Hit paper breakdown → | 2006 | 550 |
| 8 | 2002 | 470 | |
| 9 | 1996 | 463 | |
| 10 | 1989 | 446 | |
| 11 | Nutrient-sensing nuclear receptors coordinate autophagy Hit paper breakdown → | 2014 | 443 |
| 12 | Asprosin, a Fasting-Induced Glucogenic Protein Hormone Hit paper breakdown → | 2016 | 436 |
| 13 | 1998 | 424 | |
| 14 | 1994 | 421 | |
| 15 | 2007 | 419 | |
| 16 | 2002 | 414 | |
| 17 | Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis Hit paper breakdown → | 2016 | 405 |
| 18 | 1992 | 403 | |
| 19 | 1981 | 401 | |
| 20 | 1995 | 397 |
About David D. Moore
David D. Moore is a scholar working on Oncology, Pharmacology, Molecular Biology, Genetics and Cellular and Molecular Neuroscience, having authored 268 papers that have together received 32.9k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (53 papers), Cholesterol and Lipid Metabolism (33 papers), Estrogen and related hormone effects (32 papers), Genomics and Chromatin Dynamics (29 papers), Pharmacogenetics and Drug Metabolism (28 papers), Nuclear Receptors and Signaling (26 papers), Peroxisome Proliferator-Activated Receptors (23 papers) and Molecular Biology Techniques and Applications (19 papers). The work is most often cited by research in Pharmacology (3.7k citations), Hepatology (2.7k citations), Oncology (6.9k citations), Endocrine and Autonomic Systems (1.3k citations) and Endocrinology, Diabetes and Metabolism (2.8k citations). David D. Moore has collaborated with scholars based in United States, South Korea and China. Frequent co-authors include Wendong Huang, Wongi Seol, Hueng-Sik Choi, P. Reed Larsen, Dennis H. Dowhan, Yoon‐Kwang Lee, Howard M. Goodman, Mohammed Qatanani, Gregory A. Brent and Richard A. Heyman. Their work appears in journals such as Molecular Endocrinology, Hepatology, Journal of Biological Chemistry, Science and Current Protocols in Molecular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.